Sponsor:
Nova Southeastern University
Code:
NCT07187388
Conditions
Amyotrophic Lateral Sclerosis (ALS)
Primary Lateral Sclerosis (PLS)
Motor Neuron Disease, Amyotrophic Lateral Sclerosis
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Transcutaneous Electrical Nerve Stimulation to reduce facial pain and improve jaw range of motion in ALS and PLS
Brief summary:
Conditions
Amyotrophic Lateral Sclerosis (ALS)
Primary Lateral Sclerosis (PLS)
Motor Neuron Disease, Amyotrophic Lateral Sclerosis
Study ID
NCT07187388
Start date
Apr 2, 2026
Status verified date
May, 2026
Completion date
Aug 13, 2026
Anticipated
Primary completion date
Aug 13, 2026
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
10 participants
Anticipated
Intervention Model
Single group
Primary purpose
Treatment
Arms
experimental: Transcutaneous electrical stimulation to reduce facial pain and improve jaw ROM in ALS and PLS.
Interventions
Transcutaneous Electrical Nerve Stimulation to reduce facial pain and improve jaw range of motion in ALS and PLS
Primary outcome measure
Central contacts
Locations
Nova Southeastern University, David and Cathy Husman Neuroscience Institute
Recruiting
Davie, Florida, United States, 33314
Contacts
Sponsor
Nova Southeastern University
Last update posted
May 27, 2026
Last verified
May, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Nova Southeastern University on 2026-05-27.